OB-002

N/A

Report date: 2025/08/31 20:00:06

Base Information

Drug NameOB-002
Drug Alias NameOB-002OB-002MOB-002OOB-002HOB-002C +[7
ClassificationBiologics > Protein drugs
Mechanisms of ActionC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsMetastatic breast cancerNeoplasm MetastasisPancreatic Neoplasms +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerNeoplasm MetastasisPancreatic Neoplasms +[7

Other Information

ATC CodeN/A
Related LinksN/A